Still River Systems Set To Launch Its Next Generation Proton Therapy System For Cancer Treatment
Still River Systems announced the successful operation of the Monarch250, a highest field and high energy cyclotron magnet.…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 Feb 09
Still River Systems announced the successful operation of the Monarch250, a highest field and high energy cyclotron magnet.…
26 Feb 09
Pharmacogenomics research and development innovator PharmaGenoma, Inc. and its subsidiary HairDX, LLC announced an exclusive agreement with Aderans…
26 Feb 09
SaltCheck, Inc. has announced the completion of a 100 subject study demonstrating the use of a novel simplified…
26 Feb 09
CombiMatrix Corporation has announced a positive preliminary data on its investigational Comprehensive Cancer Array (CCA) test showing it…
26 Feb 09
Globus Medical, Inc. announced the full launch of its INDEPENDENCE Spacer System which is designed to provide a…
26 Feb 09
Genzyme Corporation announced that the US Food and Drug Administration (FDA) has granted marketing approval for Synvisc-One (hylan…
26 Feb 09
Quick-Med Technologies, Inc. announced today that it has received clearance from the US Food and Drug Administration to…
26 Feb 09
A-dec 300 allows unprecedented integration of technology for its class and is well-positioned to fit small spaces and…
26 Feb 09
Sanofi-aventis announced that the US FDA has approved Apidra SoloSTAR (insulin glulisine [rDNA origin] injection). It is a…
26 Feb 09
Urodynamix Technologies Ltd. announced that it has obtained a CE Mark for the UroNIRS 2000 Bladder Monitor System…